Skip to main content
. 1999 Oct;48(4):553–563. doi: 10.1046/j.1365-2125.1999.00051.x

Figure 3.

Figure 3

Serum concentration–time profiles of tolterodine and its metabolites after treatment with tolterodine (2 mg twice daily) for 2.5 days in EM2 [———]; EM1 [○]) and PM (•). 5-HM, 5-hydroxymethyl tolterodine; LOQ, limit of quantification; PM, poor metabolizers; EM, extensive metabolizers.